Q&A

Zoom On The Importance Of Quality For Viral Vector Manufacturing Optimization

Source: Polyplus
Pharma bioprocess quality GettyImages-1138461306
Industry experts offer advice on the use of GMP raw materials for viral vector manufacturing along with the key points of evolution relating to regulatory guidance and requirements for viral vector production and chief resulting considerations for manufacturers. Learn about their concerns relating to regulatory disharmony between the US and Europe and how can you avoid or mitigate risk in making changes to an AAV vector bioprocess.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene